IE
CLPT icon

Israel Englander’s ClearPoint Neuro CLPT Stock Holding History

Israel Englander’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.38M Buy
357,676
+125,702
+54% +$1.57M ﹤0.01% 2761
2026
Q1 		$2.11M Sell
231,974
-283,401
-55% -$3.58M ﹤0.01% 3824
2025
Q4 		$7.05M Buy
515,375
+327,574
+174% +$6.07M ﹤0.01% 2645
2025
Q3 		$4.09M Buy
187,801
+87,930
+88% +$1.04M ﹤0.01% 3348
2025
Q2 		$1.19M Sell
99,871
-641,322
-87% -$8.07M ﹤0.01% 4277
2025
Q1 		$8.81M Buy
741,193
+452,043
+156% +$7.03M ﹤0.01% 2314
2024
Q4 		$4.45M Buy
289,150
+13,866
+5% +$180K ﹤0.01% 2920
2024
Q3 		$3.09M Sell
275,284
-190,197
-41% -$1.82M ﹤0.01% 3276
2024
Q2 		$2.51M Buy
465,481
+405,128
+671% +$2.34M ﹤0.01% 3338
2024
Q1 		$410K Buy
+60,353
New +$422K ﹤0.01% 4938
2023
Q3 		– Sell
-35,461
Closed -$257K – 6177
2023
Q2 		$257K Sell
35,461
-200,270
-85% -$1.7M ﹤0.01% 4990
2023
Q1 		$1.99M Buy
235,731
+118,162
+101% +$1.04M ﹤0.01% 3452
2022
Q4 		$996K Buy
117,569
+15,420
+15% +$146K ﹤0.01% 4171
2022
Q3 		$1.06M Sell
102,149
-88,397
-46% -$1.16M ﹤0.01% 4288
2022
Q2 		$2.49M Buy
+190,546
New +$1.95M ﹤0.01% 3480
2021
Q3 		– Sell
-51,020
Closed -$974K – 6829
2021
Q2 		$974K Sell
51,020
-140,764
-73% -$2.72M ﹤0.01% 4691
2021
Q1 		$4.05M Buy
191,784
+116,324
+154% +$2.49M ﹤0.01% 2808
2020
Q4 		$1.2M Buy
75,460
+48,156
+176% +$432K ﹤0.01% 3619
2020
Q3 		$149 Sell
27,304
-15,763
-37% -$69.5K ﹤0.01% 4143
2020
Q2 		$155K Sell
43,067
-10,294
-19% -$38.3K ﹤0.01% 3907
2020
Q1 		$191K Sell
53,361
-18,112
-25% -$89K ﹤0.01% 3406
2019
Q4 		$343K Sell
71,473
-43,811
-38% -$181K ﹤0.01% 3593
2019
Q3 		$583K Buy
+115,284
New +$472K ﹤0.01% 3156

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Israel Englander's CLPT Position: Q2 2026 in Review

Israel Englander increased its ClearPoint Neuro (CLPT) stake by 54% in Q2 2026, buying an estimated $1.57M and bringing the position to 357,676 shares worth $6.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2761.

Israel Englander first reported a position in CLPT in Q3 2019 and has held it in 23 quarters since. The position peaked at $8.81M in Q1 2025. 128 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Israel Englander held 357,676 shares of ClearPoint Neuro worth $6.38M as of Q2 2026.
  • Israel Englander bought 125,702 ClearPoint Neuro shares in Q2 2026, an estimated $1.57M.
  • ClearPoint Neuro made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2761 holding.
  • Israel Englander first reported a position in ClearPoint Neuro in Q3 2019 and has held it in 23 quarters since.
  • Israel Englander's ClearPoint Neuro position peaked at $8.81M in Q1 2025.
  • 128 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.